Skip to main content
Smart Investors Daily
MD

OTC · MDRX

Veradigm Inc.

Healthcare · Medical - Healthcare Information Services

$4.95

Down-$0.00 (-0.08%)

Updated Aug 21, 2026, 10:22 AM

SID Score

5.4/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
823.68M
P/E ratio
-7.23
Dividend yield
0.00%
52-week range
— – —
Volume
450
Avg. volume
109.14K

Price performance

MDRX price history

1M range · 0 trading sessions · Daily adjusted prices

MDRX does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest MDRX news

The latest Smart Investors Daily articles mentioning MDRX.

MDRX research

Overview

Company profile and research snapshot.

Company profile

VERADIGM INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$16.17
Implied upside
Analysts
10
MDRX recent ratings
DateFirmRatingTarget
Jan 31, 2025Stephens & Co.Equal-Weight
May 28, 2024TD CowenBuy
Mar 19, 2024Deutsche BankHold
Jan 19, 2024RBC CapitalOutperform
Jan 3, 2024BarclaysEqual-Weight
Open full forecast

News briefing

No generated briefing is available yet.

businesswire.com · Nov 17, 2025

Veradigm Launches Enhanced Ambient Scribe Capabilities

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced enhancements to the artificial intelligence (AI) enhanced Ambient Scribe solution for Veradigm EHR customers. This milestone reflects Veradigm's commitment to delivering evolved AI solutions that improve clinical documentation, support clinical decision-making, and enhance patient care. Since its launch last year, Veradigm Ambient Scribe has developed into a robus.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.